Barclays Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $17.00

Acadia Healthcare (NASDAQ:ACHC) had its target price decreased by research analysts at Barclays from $20.00 to $17.00 in a note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s price objective indicates a potential downside of 12.87% from the company’s previous close.

ACHC has been the subject of several other reports. Royal Bank Of Canada lowered their price target on shares of Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. Cowen reaffirmed a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Sunday, August 3rd. Cantor Fitzgerald restated a “neutral” rating and set a $25.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 7th. Finally, Raymond James Financial raised their price objective on shares of Acadia Healthcare from $26.00 to $30.00 and gave the company an “outperform” rating in a report on Friday, October 3rd. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $33.55.

Acadia Healthcare Stock Down 3.7%

Shares of NASDAQ ACHC opened at $19.51 on Thursday. The company has a market cap of $1.80 billion, a price-to-earnings ratio of 12.92, a PEG ratio of 4.56 and a beta of 0.97. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. Acadia Healthcare has a 12 month low of $17.13 and a 12 month high of $47.08. The stock has a 50-day moving average price of $23.34 and a two-hundred day moving average price of $22.78.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. The company had revenue of $851.57 million for the quarter, compared to analyst estimates of $852.43 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The firm’s revenue was up 4.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. GSA Capital Partners LLP lifted its position in shares of Acadia Healthcare by 40.0% in the 3rd quarter. GSA Capital Partners LLP now owns 47,710 shares of the company’s stock worth $1,181,000 after purchasing an additional 13,633 shares during the period. Vanguard Group Inc. lifted its holdings in Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock valued at $233,166,000 after buying an additional 681,278 shares during the period. JPMorgan Chase & Co. boosted its position in Acadia Healthcare by 22.3% during the third quarter. JPMorgan Chase & Co. now owns 203,658 shares of the company’s stock valued at $5,043,000 after acquiring an additional 37,107 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in Acadia Healthcare by 45.8% during the 3rd quarter. PNC Financial Services Group Inc. now owns 12,343 shares of the company’s stock worth $306,000 after acquiring an additional 3,877 shares during the period. Finally, Aberdeen Group plc raised its position in shares of Acadia Healthcare by 24.0% in the 3rd quarter. Aberdeen Group plc now owns 431,753 shares of the company’s stock worth $10,690,000 after acquiring an additional 83,636 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.